ten Cate JW - Search Results

1

Recombinant, B-domain deleted factor VIII (r-VIII SQ): pharmacokinetics and initial safety aspects in hemophilia A patients.

Fijnvandraat K, Berntorp E, ten Cate JW, Johnsson H, Peters M, Savidge G, Tengborn L, Spira J, Stahl C. Fijnvandraat K, et al. Among authors: ten cate jw. Thromb Haemost. 1997 Feb;77(2):298-302. Thromb Haemost. 1997. PMID: 9157585 Clinical Trial.

2

Inter-individual variation in half-life of infused recombinant factor VIII is related to pre-infusion von Willebrand factor antigen levels.

Fijnvandraat K, Peters M, ten Cate JW. Fijnvandraat K, et al. Among authors: ten cate jw. Br J Haematol. 1995 Oct;91(2):474-6. doi: 10.1111/j.1365-2141.1995.tb05325.x. Br J Haematol. 1995. PMID: 8547097 Clinical Trial.

3

Coagulation activation and tissue necrosis in meningococcal septic shock: severely reduced protein C levels predict a high mortality.

Fijnvandraat K, Derkx B, Peters M, Bijlmer R, Sturk A, Prins MH, van Deventer SJ, ten Cate JW. Fijnvandraat K, et al. Among authors: ten cate jw. Thromb Haemost. 1995 Jan;73(1):15-20. Thromb Haemost. 1995. PMID: 7740486

4

Factor VIII inhibitor associated with ciprofloxacin.

van Beek EJ, Peters M, ten Cate JW. van Beek EJ, et al. Among authors: ten cate jw. Thromb Haemost. 1993 Apr 1;69(4):403. Thromb Haemost. 1993. PMID: 8497856 No abstract available.

5

A human alloantibody interferes with binding of factor IXa to the factor VIII light chain.

Fijnvandraat K, Celie PH, Turenhout EA, ten Cate JW, van Mourik JA, Mertens K, Peters M, Voorberg J. Fijnvandraat K, et al. Among authors: ten cate jw. Blood. 1998 Apr 1;91(7):2347-52. Blood. 1998. PMID: 9516133 Free article.

6

The missense mutation Arg593 --> Cys is related to antibody formation in a patient with mild hemophilia A.

Fijnvandraat K, Turenhout EA, van den Brink EN, ten Cate JW, van Mourik JA, Peters M, Voorberg J. Fijnvandraat K, et al. Among authors: ten cate jw. Blood. 1997 Jun 15;89(12):4371-7. Blood. 1997. PMID: 9192760 Free article.

7

Antithrombin acts as a negative acute phase protein as established with studies on HepG2 cells and in baboons.

Niessen RW, Lamping RJ, Jansen PM, Prins MH, Peters M, Taylor FB Jr, de Vijlder JJ, ten Cate JW, Hack CE, Sturk A. Niessen RW, et al. Among authors: ten cate jw. Thromb Haemost. 1997 Sep;78(3):1088-92. Thromb Haemost. 1997. PMID: 9308758

8

Endotoxin induced coagulation activation and protein C reduction in meningococcal septic shock.

Fijnvandraat K, Peters M, Derkx B, van Deventer S, ten Cate JW. Fijnvandraat K, et al. Among authors: ten cate jw. Prog Clin Biol Res. 1994;388:247-54. Prog Clin Biol Res. 1994. PMID: 7831362 Review. No abstract available.

9

Impaired fibrinolysis in the hemolytic-uremic syndrome of childhood.

Menzel D, Levi M, Dooijewaard G, Peters M, ten Cate JW. Menzel D, et al. Among authors: ten cate jw. Ann Hematol. 1994 Jan;68(1):43-8. doi: 10.1007/BF01695919. Ann Hematol. 1994. PMID: 8110878

10

Thrombosis prophylaxis in an AT III deficient pregnant woman: application of a low molecular weight heparinoid.

Henny CP, ten Cate H, ten Cate JW, Prummel MF, Peters M, Büller HR. Henny CP, et al. Among authors: ten cate jw, ten cate h. Thromb Haemost. 1986 Apr 30;55(2):301. Thromb Haemost. 1986. PMID: 3715796 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

339 results

Search Page

Filters